References
- Adams P., White C. Isoniazid-induced encephalopathy. Lancet 1965; I: 680–682
- Barron G. J., Tepper L., Iovine G. Ocular toxicity from ethambutol. Amer. J. Ophthal. 1974; 77: 256–260
- Bender D. A., Russell-Jones R. Isoniazid-induced pellagra despite vitamin B6 supplementation. Lancet 1979; II: 1125–1126
- Biehl J. P., Vilter R. W. Effect of isoniazid on vitamin B6 metabolism: its possible significance in producing isoniazid neuritis. Proc, Soc. exp. Biol. Med. 1954; 85: 389–392
- Blakemore W. F. Isoniazid. Experimental and Clinical Neurotoxicology, P. S. Spencer, H. H. Schaumburg). Williams & Wilkins, Baltimore 1980; 476–489
- Blakemore W. E, Palmer A. C., Noel P. R. B. Ultrastructural changes in isoniazid-induced brain edema in the dog. J. Neurocytol. 1972; I: 263–278
- Carr R. E., Henkind P. Ocular manifestations of ethambutol. Arch. Ophthal. 1962; 67: 566–571
- Citron K. M. Ethambutol: A review with special references to ocular toxicity. Tubercle 1969; 50: 32–36, Suppl
- Delacoux R., Moreau Y., Godefroy A., Evstigneeff T. Prévention de la toxicité oculaire de ľéthambutol: intérět de la zincémie et de Panalyse du sens chromatique. J. fr. Ophtal. 1978; 1: 191–196
- Gerard G., Weisberg L. A. Magnetic resonance imaging in adult white matter disorders and hydrocephalus. Sem. Neurol. 1986; 6: 17–23
- Girling D. J. Adverse effects of antituberculosis drugs. Drugs 1982; 23: 56–74
- Grunwald G. B., Klein R., Simmonds M. A., Kornguth S. E. Autoimmune basis for visual paraneoplastic syndrome in patients with small-cell carcinoma. Lancet 1985; I: 658–661
- Hughes R. A. C., Mair W. G. P. Acute necrotic myelopathy with pulmonary tuberculosis. Brain 1977; 100: 223–238
- Karmon G., Savir H., Zevin D., Levi J. Bilateral optic neuropathy due to combined ethambutol and isoniazid treatment. Ann. Ophthal. 1979; II: 1013–1017
- Kiyosawa M., Ishikawa S. A case of isoniazid-induced optic neuropathy. Neuro-Ophthalmology (Amsterdam) 1981; 2: 67–70
- Leibold J. E. The ocular toxicity of ethambutol and its relationship to dose. Ann. NY Acad. Sci. 1966; 135: 904–909
- Lunde P. K. M., Frislid K., Hansteen V. Disease and acetylation polymorphism. Clin. Pharmacokinet. 1977; 2: 182–197
- Nair V. S., Lebrun M., Kass I. Peripheral neuropathy associated with ethambutol. Chest 1980; 77: 98–100
- Takeuchi T, Takahashi M., Kang J., et al. Ethambutol neuropathy: clinical and electromyographic studies. Folia psychiat. neurol. jap. 1980; 34: 45–55
- Walsh F. B., Hoyt W. F. Clinical Neuro-Ophthalmology. Williams & Wilkins, Baltimore 1982; Vol I: 254–260; 289–307
- Wlsniewski H. M., Bloom B. R. Experimental allergic optic neuritis (EAON) in the rabbit. A new model to study primary demyelinating diseases. J. Neurol. Sci 1975; 24: 257–263
- Yiannikas C, Walsh J. C., McLeod J. G. Visual evoked potentials in the detection of subclinical optic toxic effects secondary to ethambutol. Arch. Neurol. 1983; 40: 645–648
- Yolton D. P. Nutritional effects of zinc on ocular and systemic physiology. J. Amer. Optom. Assoc. 1981; 52: 409–414